Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,589 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ZNF492 and GPR149 methylation patterns as prognostic markers for clear cell renal cell carcinoma: Array‑based DNA methylation profiling.
Kim YJ, Jang W, Piao XM, Yoon HY, Byun YJ, Kim JS, Kim SM, Lee SK, Seo SP, Kang HW, Kim WT, Yun SJ, Shon HS, Ryu KH, Kim SW, Ha YS, Yoon GS, Lee SC, Kwon TG, Kim WJ. Kim YJ, et al. Among authors: kim wj, kim sw, kim js, kim sm, kim wt. Oncol Rep. 2019 Jul;42(1):453-460. doi: 10.3892/or.2019.7151. Epub 2019 May 7. Oncol Rep. 2019. PMID: 31115548
The age-adjusted Charlson comorbidity index as a predictor of overall survival of surgically treated non-metastatic clear cell renal cell carcinoma.
Kang HW, Kim SM, Kim WT, Yun SJ, Lee SC, Kim WJ, Hwang EC, Kang SH, Hong SH, Chung J, Kwon TG, Kim HH, Kwak C, Byun SS, Kim YJ; KORCC (KOrean Renal Cell Carcinoma) Group. Kang HW, et al. Among authors: kim hh, kim yj, kim wj, kim sm, kim wt. J Cancer Res Clin Oncol. 2020 Jan;146(1):187-196. doi: 10.1007/s00432-019-03042-7. Epub 2019 Oct 12. J Cancer Res Clin Oncol. 2020. PMID: 31606760
Intraoperative allogeneic blood transfusion is associated with adverse oncological outcomes in patients with surgically treated non-metastatic clear cell renal cell carcinoma.
Kang HW, Seo SP, Kim WT, Yun SJ, Lee SC, Kim WJ, Hwang EC, Kang SH, Hong SH, Chung J, Kwon TG, Kim HH, Kwak C, Byun SS, Kim YJ; KORCC (KOrean Renal Cell Carcinoma) Group. Kang HW, et al. Among authors: kim hh, kim yj, kim wj, kim wt. Int J Clin Oncol. 2020 Aug;25(8):1551-1561. doi: 10.1007/s10147-020-01694-x. Epub 2020 Jun 5. Int J Clin Oncol. 2020. PMID: 32504136
Surgical margin does not influence recurrence rate in pT1 clear cell renal cell carcinoma after partial nephrectomy: A multicenter study.
Kang HW, Lee SK, Kim WT, Yun SJ, Lee SC, Kim WJ, Hwang EC, Kang SH, Hong SH, Chung J, Kwon TG, Kim HH, Kwak C, Byun SS, Kim YJ; KORCC (KOrean Renal Cell Carcinoma) Group. Kang HW, et al. Among authors: kim hh, kim yj, kim wj, kim wt. J Surg Oncol. 2016 Jul;114(1):70-4. doi: 10.1002/jso.24259. Epub 2016 Apr 13. J Surg Oncol. 2016. PMID: 27074886
PFKFB4 as a prognostic marker in non-muscle-invasive bladder cancer.
Yun SJ, Jo SW, Ha YS, Lee OJ, Kim WT, Kim YJ, Lee SC, Kim WJ. Yun SJ, et al. Among authors: kim yj, kim wj, kim wt. Urol Oncol. 2012 Nov-Dec;30(6):893-9. doi: 10.1016/j.urolonc.2010.08.018. Epub 2011 Mar 10. Urol Oncol. 2012. PMID: 21396842
12,589 results
You have reached the last available page of results. Please see the User Guide for more information.